The WACC of Patientsky Group AS (PSKY.OL) is 6.1%.
Range | Selected | |
Cost of equity | 6.0% - 8.2% | 7.1% |
Tax rate | 16.9% - 21.8% | 19.35% |
Cost of debt | 5.0% - 5.0% | 5% |
WACC | 5.4% - 6.8% | 6.1% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 5.5% | 6.5% |
Adjusted beta | 0.39 | 0.51 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 6.0% | 8.2% |
Tax rate | 16.9% | 21.8% |
Debt/Equity ratio | 0.46 | 0.46 |
Cost of debt | 5.0% | 5.0% |
After-tax WACC | 5.4% | 6.8% |
Selected WACC | 6.1% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
PSKY.OL | Patientsky Group AS | 0.46 | -0.25 | -0.18 |
ALMDT.PA | Median Technologies SA | 0.44 | -0.45 | -0.33 |
CONTX.OL | ContextVision AB | 0.03 | 0.45 | 0.44 |
CRW.L | Craneware PLC | 0.05 | 0.6 | 0.58 |
CSAM.OL | Csam Health Group AS | 0.7 | -0.67 | -0.42 |
GPI.MI | GPI SpA | 1.48 | 0.49 | 0.22 |
INS.L | Instem PLC | 0.01 | 0.56 | 0.55 |
MDA.WA | Medapp SA | 0.01 | 0.62 | 0.61 |
SDT.PA | Visiodent SA | 0.19 | -0.21 | -0.18 |
SENS.L | Sensyne Health PLC | 1.63 | 0.16 | 0.07 |
Low | High | |
Unlevered beta | -0.03 | 0.31 |
Relevered beta | 0.09 | 0.27 |
Adjusted relevered beta | 0.39 | 0.51 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for PSKY.OL:
cost_of_equity (7.10%) = risk_free_rate (4.15%) + equity_risk_premium (6.00%) * adjusted_beta (0.39) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.